Cell cultures of and cell culturing method for nontransformed pancreatic, thyroid, and parathyroid cells

• US 5,888,816 A
• Filed: 06/07/1995
• Issued: 03/30/1999
• Est. Priority Date: 04/08/1993
• Status: Expired due to Fees

• Current Assignee: Ambesi-Impiombato F. Saverio, Francesco Curcio, Hayden G. Coon
• Original Assignee: Human Cell Cultures, Inc.
• Inventors: Ambesi-Impiombato, Francesco Saverio, Curcio, Francesco, Coon, Hayden G.
• Primary Examiner(s): Lankford, Jr., Leon B.
• Assistant Examiner(s): TATE, CHRISTOPHER ROBIN
• Application Number:
  US08/480,022
• Time in Patent Office: 1,392 Days
• Field of Search: 435/240.2, 435/240.21, 435/240.3, 435/240.31, 435/404, 435/408, 435/325, 435/366, 435/378, 435/382, 435/383, 435/391, 435/392
• US Class Current: 435/366
• CPC Class Codes: A61K 35/12 Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells vaccines or medicinal preparations containing antigens or antibodies A61K39/00
• CPC Class Codes: A61K 35/39 Pancreas; Islets of Langerhans Langerhans cells of epidermis A61K35/36
• CPC Class Codes: A61P 3/08 for glucose homeostasis pancreatic hormones A61P5/48
• CPC Class Codes: C12N 2500/16 Magnesium; Mg chelators
• CPC Class Codes: C12N 2500/25 Insulin-transferrin; Insulin-transferrin-selenium
• CPC Class Codes: C12N 2500/32 Amino acids
• CPC Class Codes: C12N 2500/34 Sugars
• CPC Class Codes: C12N 2500/38 Vitamins
• CPC Class Codes: C12N 2500/84 from mammals
• CPC Class Codes: C12N 2501/39 Steroid hormones
• CPC Class Codes: C12N 2501/395 Thyroid hormones
• CPC Class Codes: C12N 2502/22 pancreatic cells
• CPC Class Codes: C12N 2510/00 Genetically modified cells
• CPC Class Codes: C12N 5/0617 Thyroid and parathyroid glands
• CPC Class Codes: C12N 5/0633 Cells of secretory glands, e.g. parotid gland, salivary glands, sweat glands, lacrymal glands
• CPC Class Codes: C12N 5/0676 Pancreatic cells

Abstract

The present invention provides a method for producing an expanded, enriched, non-transformed human cell culture of human pancreatic, thyroid or parathyroid endocrine cells and other types of cells which comprises (1) preparing partially purified, minced tissue that includes a desired type of cells; (2) concentrating the desired cells; (3) resuspending the concentrated cells in a growth medium which selects in favor of the desired cells and in which those cells are proliferated without being transformed and differentiated functions are retained through periodic passaging; (4) culturing the resuspended cells in the growth medium to effect sustained cell division; and (5) passaging the cultured cells periodically to expand the culture. The present invention further provides clonal strains of cells derived from the above-mentioned cell culture and procedures to form matrix-embedded aggregated and non-aggregated cells for providing pseudotissues and products such as matrix-embedded pancreatic islets (pseudoislets). Growth medium and conditioned medium is provided for the culturing of the cells and clonal strains, the growth medium comprising a suitable basal medium supplemented with effective concentrations of hypothalamus and pituitary extracts, serum and other ingredients, which growth medium selects in favor of desired human cells and against passenger cells including fibroblast, macrophage, and capillary endothelial cells such that the desired cells are selectively proliferated without being transformed and an expanded cell culture is provided of functionally differentiated, expanded, non-transformed human cells that is substantially free of such passenger cells.

Claims

1. A method for producing an expanded, enriched, non-transformed human cell culture of human pancreatic endocrine cells comprising the steps of:

(a) selecting said cells from a human tissue that comprises said cells;

(b) concentrating said cells selected in step (a);

(c) resuspending said cells concentrated in step (b) in a growth medium;

(d) culturing said cells resuspended in step (c) in said growth medium to effect sustained cell division; and

(e) passaging said cells cultured in step (d) periodically to expand said culture;

wherein said growth medium comprises a combination of a suitable basal medium and supplements of ingredients including hypothalamus and pituitary extracts, and serum, which ingredients of the growth medium are adjusted in amounts to provide a medium which is selective for said human cells and in which said human cells are selectively proliferated without being transformed and differentiated functions are retained through periodic passaging, providing an expanded human cell culture of functionally differentiated, expanded, non-transformed human cells that is substantially free of passenger cells including fibroblast, macrophage, and capillary endothelial cells.

2. The method of claim 1, wherein said basal medium is further supplemented with one or both of human placental extract or human placental lactogen.

3. The expanded, non-transformed human cell culture produced by the method of claim 2.

4. The method of claim 2, wherein said human pancreatic endocrine cells are selected from the group consisting of alpha cells, beta cells, delta cells, and mixtures thereof.

5. The method of claim 2, wherein said human pancreatic endocrine cells comprise at least two different types of pancreatic endocrine cells selected from the group consisting of alpha cells, beta cells, and delta cells.

6. The method of claim 1, wherein said expanded human cell culture comprises pluripotent cells.

7. The method of claim 6, wherein said pluripotent cells provide populations of cells that contain at least one islet cell type.

8. The expanded, non-transformed cell culture produced by the method of claim 7.

9. The expanded, non-transformed human cell culture produced by the method of claim 1.

10. The method of claim 1 wherein said human pancreatic endocrine cells are obtained from an adult.

11. The method of claim 1, wherein said expanded human cell culture of pancreatic endocrine cells contains at least one islet cell type.

12. The method of claim 1, wherein said expanded human cell culture of pancreatic endocrine cells has undergone at least seven population doublings (7 PDL).

13. The method of claim 12, wherein said expanded human cell culture of pancreatic endocrine cells contains aggregated cells, non-aggregated cells and mixtures thereof.

14. The method of claim 13, wherein said aggregated cells, non-aggregated cells and mixtures thereof are embedded in a biocompatible gel.

15. The aggregated cells, non-aggregated cells and mixtures thereof embedded in a biocompatible gel produced by the method of claim 14.

16. A method for preparing clonal strains of an expanded, enriched, non-transformed cell culture of human pancreatic endocrine cells, comprising the steps of:

(a) culturing the expanded human cell culture obtained according to the method of claim 1 and using the growth medium thereof;

(b) growing said expanded human cell culture to confluence;

(c) dissociating said cells;

(d) innoculating said disassociated cells into a culture vessel that contains a conditioned culture medium that has been conditioned by said human cells for a first plating and culturing said inoculated cells to produce colonies of cells;

(e) harvesting individual colonies of cells;

(f) inoculating said colonies into a culture vessel for a second plating and culturing said inoculated cells; and

(g) passaging the cells of step (f) periodically.

17. The clonal strains of an expanded non-transformed cell culture of human pancreatic endocrine cells produced by the method of claim 16, wherein said expanded cell culture of step (a) obtained according to the method of claim 1 has undergone at least seven population doublings (7 PDL).

18. A method for producing an expanded, enriched, non-transformed human cell culture of human cells selected from the group consisting of thyroid endocrine and parathyroid endocrine cells comprising:

(a) selecting said cells from a human tissue that comprises said cells;

(b) concentrating said cells selected in (a);

(c) resuspending said cells concentrated in (b) in a growth medium;

(d) culturing said cells resuspended in (c) in said growth medium to effect sustained cell division; and

(e) passaging said cells cultured in (d) periodically to expand said culture;

wherein said growth medium comprises a combination of a suitable basal medium and supplements of ingredients including about 0.48 mM MgCl₂, about 0.01 mM hydrocortisone, about 2 ng/ml selenous acid, about 3 pg/ml triiodothyronine, about 75 μ

g/ml bovine hypothalamus extract, about 5 μ

g/ml bovine pituitary extract, and serum, which ingredients of the growth medium are present in concentrations effective to provide a medium which is selective for said human cells and in which said human cells are selectively proliferated without being transformed and differentiated functions are retained through periodic passaging, providing an expanded human cell culture of functionally differentiated, expanded, non-transformed human cells that is substantially free of passenger cells including fibroblast, macrophage, and capillary endothelial cells.

19. The expanded, non-transformed cell culture produced by the method of claim 18.

20. The method of claim 18 wherein said expanded human cell culture comprises thyroid endocrine cells.

21. A method for producing an expanded, enriched, non-transformed human cell culture of human pancreatic endocrine cells, comprising:

(a) selecting said pancreatic endocrine cells from human pancreatic tissue;

(b) concentrating said selected cells;

(c) resuspending said concentrated cells in a growth medium;

(d) culturing said resuspended cells to effect sustained cell division; and

(e) passaging said cultured cells periodically to expand said culture;

wherein said growth medium comprises a combination of a suitable basal medium and supplements of ingredients including hypothalamus and pituitary extracts, one or both of placental extract or human placental lactogen, and serum, which ingredients of said growth medium are adjusted in amounts to be effective to provide a medium which promotes sustained cell division of the cultured pancreatic endocrine cells and selects in favor of the cultured pancreatic endocrine cells and in which said cultured pancreatic endocrine cells are selectively proliferated without being transformed and differentiated functions are retained through periodic passaging, providing an expanded human pancreatic cell culture of functionally differentiated, expanded, non-transformed human pancreatic endocrine cells that is substantially free of passenger cells including fibroblast, macrophage, and capillary endothelial cells.

22. The method of claim 21 wherein said expanded human pancreatic endocrine cell culture has undergone at least seven population doublings (7 PDL).

23. The expanded, non-transformed human cell culture produced according to the method of claim 21 wherein the human pancreatic endocrine cells of said cell culture secrete insulin at a steady state and secrete elevated levels of insulin in response to glucose stimulation.

24. The expanded, non-transformed human cell culture of claim 23, wherein said human pancreatic endocrine cells of said cell culture do not grow in soft agar, have a normal karyotype, and do not form tumors in 45 days after about 10⁷ cells are implanted into SCID mice.

25. A method for producing an expanded, enriched, non-transformed human cell culture consisting essentially of human pancreatic endocrine cells comprising:

(a) selecting human pancreatic endocrine cells from a human tissue;

(b) concentrating said cells selected in (a);

(c) resuspending said cells concentrated in (b) in a growth medium;

(d) culturing said cells resuspended in (c) to effect sustained cell division; and

(e) passaging said cells cultured in (d) periodically to expand said culture;

wherein said growth medium comprises a basal medium and supplements of ingredients including hypothalamus and pituitary extracts, serum and calcium, which ingredients of said growth medium are adjusted in amounts to be effective provide a medium which is selective for said human cells and in which said human cells are selectively proliferated without being transformed and differentiated functions are retained through periodic passaging, providing an expanded human pancreatic endocrine cell culture that is substantially free of passenger cells including fibroblast, macrophage, and capillary endothelial cells.

26. The method of claim 25, wherein said human pancreatic endocrine cells of said expanded cell culture do not grow in soft agar, have a normal karyotype, and do not form tumors in 45 days after about 10⁷ cells are implanted into SCID mice.

27. A method for producing an expanded, enriched, non-transformed human cell culture of human thyroid endocrine or parathyroid endocrine cells comprising:

(a) selecting said cells from a human tissue that comprises said cells;

(b) concentrating said selected cells;

(c) resuspending said concentrated cells in a growth medium;

(d) culturing said resuspended cells in said growth medium to effect sustained cell division; and

(e) passaging said cultured cells periodically to expand said culture;

wherein said growth medium comprises a combination of a suitable basal medium and supplements of ingredients including MgCl₂, hydrocortisone, selenous acid, triiodothyronine, hypothalamus extract, pituitary extract, and serum, which ingredients of the growth medium are adjusted in amounts to be effective to provide a medium which is selective for said human cells and in which said human cells are selectively proliferated without being transformed and differentiated functions are retained through periodic passaging, providing an expanded human cell culture of functionally differentiated, expanded, non-transformed human thyroid endocrine cells or parathyroid endocrine cells that is substantially free of passenger cells including fibroblast, macrophage, and capillary endothelial cells.

28. The method of claim 27, wherein said expanded human cell culture of thyroid or parathyroid cells has undergone at least seven population doublings (7 PDL).

29. The method of claim 28, wherein said expanded human cell culture of thyroid or parathyroid cells contains aggregated cells, non-aggregated cells and mixtures thereof.

30. The method of claim 29, wherein said aggregated cells, non-aggregated cells and mixtures thereof are embedded in a biocompatible gel.

31. The aggregated cells, non-aggregated cells and mixtures thereof embedded in a biocompatible gel produced by the method of claim 30.

32. The expanded non-transformed thyroid endocrine or parathyroid endocrine cell culture produced by the method of claim 27.

33. A method for preparing clonal strains of an expanded, enriched, non-transformed cell culture of human thyroid endocrine or parathyroid endocrine cells comprising:

(f) culturing an expanded human cell culture obtained according to the method of claim 27 and using the growth medium thereof;

(h) growing said expanded human cell culture to confluence;

(i) dissociating cells of said expanded human cell culture of (h);

(j) innoculating said disassociated cells of (i) into a culture vessel that contains a conditioned culture medium that has been conditioned by said human cells for a first plating and culturing said inoculated cells to produce colonies of cells;

(k) harvesting said individual colonies of cells;

(l) inoculating said individual colonies of cells into a culture vessel for a second plating and culturing said inoculated cells; and

(m)passaging the cultured cells of (l) periodically.

34. The clonal strains of an expanded non-transformed thyroid endocrine or parathyroid endocrine cell culture produced by the method of claim 33.